Literature DB >> 12394866

Improving ventricular-arterial coupling during resuscitation from shock: effects on cardiovascular function and systemic perfusion.

Michael C Chang1, R Shayn Martin, Lynette A Scherer, J Wayne Meredith.   

Abstract

BACKGROUND: Efficacy of circulation depends on interactions between the heart and the vascular system. Ventricular-arterial coupling (VAC) has been described as an important determinant of cardiovascular function during resuscitation from shock. However, no prospective studies examining VAC and systemic perfusion have been performed. VAC is measured by the ratio of afterload (aortic input impedance [E ]) to contractility (end-systolic elastance [E ]). Lowering E /E is associated with better VAC and improved myocardial work efficiency. Our hypothesis was that optimizing VAC during resuscitation results in improved myocardial work efficiency while simultaneously improving systemic perfusion.
METHODS: This was a prospective study in a consecutive series of critically injured patients. Hemodynamic variables, including E, E, and myocardial work efficiency were evaluated by constructing ventricular pressure-volume loops at the bedside during resuscitation. After pulmonary artery catheterization and adequate fluid resuscitation, left ventricular power output and E /E were optimized with inotropic agents and/or afterload reduction. Efficiency was calculated as stroke work/total left ventricular energy expenditure. Tissue perfusion was estimated by calculating base deficit clearance per hour.
RESULTS: Twenty-three patients were studied over a 9-month period. Fifteen patients required inotropic support or afterload reduction. Improvements were seen in E /E (from 1.0 +/- 0.4 to 0.6 +/- 0.2 mm Hg/mL/m, p = 0.0004), and left ventricular power output (from 280 +/- 77 to 350 +/- 81 L/min/m. mm Hg, p = 0.003) with resuscitation. A concomitant improvement in myocardial efficiency (from 70% +/- 8.0% to 77% +/- 5.0%, p = 0.0001) and base deficit clearance (from 0.1 +/- 0.4 to -0.2 +/- 0.1 mEq/L/h, p = 0.006) was seen.
CONCLUSION: Improved ventricular-arterial coupling during resuscitation is associated with improved myocardial efficiency and systemic tissue perfusion. Perfusion can be improved at lower energy cost to the heart by focusing on thermodynamic principles during resuscitation.

Entities:  

Mesh:

Year:  2002        PMID: 12394866     DOI: 10.1097/00005373-200210000-00010

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  5 in total

1.  Role of Electromechanical Dyssynchrony Assessment During Acute Circulatory Failure and Its Relation to Ventriculo-Arterial Coupling.

Authors:  Stefan Andrei; Bogdan A Popescu; Vincenza Caruso; Maxime Nguyen; Belaid Bouhemad; Pierre-Grégoire Guinot
Journal:  Front Cardiovasc Med       Date:  2022-06-21

Review 2.  Critical care considerations in the management of the trauma patient following initial resuscitation.

Authors:  Roger F Shere-Wolfe; Samuel M Galvagno; Thomas E Grissom
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2012-09-18       Impact factor: 2.953

3.  Combining Physiology-Based Modeling and Evolutionary Algorithms for Personalized, Noninvasive Cardiovascular Assessment Based on Electrocardiography and Ballistocardiography.

Authors:  Nicholas Mattia Marazzi; Giovanna Guidoboni; Mohamed Zaid; Lorenzo Sala; Salman Ahmad; Laurel Despins; Mihail Popescu; Marjorie Skubic; James Keller
Journal:  Front Physiol       Date:  2022-01-12       Impact factor: 4.566

4.  Ventriculo-Arterial Coupling Is Associated With Oxygen Consumption and Tissue Perfusion in Acute Circulatory Failure.

Authors:  Stefan Andrei; Maxime Nguyen; Dan Longrois; Bogdan A Popescu; Belaid Bouhemad; Pierre-Grégoire Guinot
Journal:  Front Cardiovasc Med       Date:  2022-02-23

5.  Optimizing left ventricular-arterial coupling during the initial resuscitation in septic shock - a pilot prospective randomized study.

Authors:  Xiaoyang Zhou; Yiqin Zhang; Jianneng Pan; Yang Wang; Hua Wang; Zhaojun Xu; Bixin Chen; Caibao Hu
Journal:  BMC Anesthesiol       Date:  2022-01-21       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.